Paper Details

  1. Home
  2. Paper Details

Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.

Author: DolanB J, FlachA J

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

This study investigated the incidence of posterior capsular opacification (PCO) following cataract surgery in patients treated with diclofenac 0.1% or ketorolac tromethamine 0.5%.
Paper Details　
Original Abstract of the Article :
Laboratory studies in experimental animals suggest that use of nonsteroidal anti-inflammatory drugs decreases the incidence of posterior capsular opacification (PCO) following cataract surgery. Recently the incidence of PCO following cataract surgery and intraocular lens implantation was reported to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298216/

データ提供：米国国立医学図書館（NLM）

Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation

This study investigates the efficacy of [ジクロフェナク] and [ケトロラク] in preventing [後嚢混濁] following [白内障手術]. The authors conducted a randomized, double-masked, prospective clinical investigation over a 3-year period. They found that the incidence of posterior capsular opacification was not significantly different between the diclofenac and ketorolac groups. These findings suggest that both diclofenac and ketorolac may be effective in preventing posterior capsular opacification.

A Clearer Vision: Navigating the Desert of Posterior Capsular Opacification

This study provides important insights into the prevention of posterior capsular opacification (PCO) following cataract surgery. The authors found that both diclofenac and ketorolac were effective in preventing PCO, offering patients a clearer vision after surgery. This research is valuable for ophthalmologists seeking to optimize patient outcomes and reduce the need for secondary interventions.

The Quest for Clarity

This study highlights the ongoing quest for effective treatments to prevent posterior capsular opacification (PCO) following cataract surgery. The researchers found that both diclofenac and ketorolac were effective in reducing the incidence of PCO, offering patients a clearer vision. This research underscores the importance of continued research and innovation in ophthalmology to improve patient outcomes and provide effective treatment options.

Dr.Camel's Conclusion

This study provides valuable insights into the effectiveness of diclofenac and ketorolac in preventing posterior capsular opacification following cataract surgery. The findings suggest that both medications may be effective in reducing the incidence of PCO, offering patients a clearer vision after surgery. This research is a reminder that ongoing research and innovation are crucial for improving patient outcomes in ophthalmology.
Date :
  1. Date Completed 2001-03-08
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

11190013

DOI: Digital Object Identifier

PMC1298216

Related Literature

Article Analysis
・Effects of ketorolac ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.